The following assignment descriptions showcase some of MMC International’s global and local expertise. They are representative of MMC's ability to handle complex assignments from conceptualization through implementation in both developed and developing markets worldwide. They span from work conducted independently to assignments undertaken with internal client teams. MMC's objective, quite simply, is to create value for our clients.
Integrated Disease Opportunity Review – evaluated competitive and marketplace factors that will impact the company’s products in a specific therapeutic area. The reviews included and ranged from legislation, regulation, new technologies, consumers, payers, providers and allied health professionals to changing disease diagnosis and management, marketed products, internal and competitor pipelines, competitor strategies, etc. The focus of these reviews has generally been to
Product Portfolio Review – the emphasis has been to assist senior management to conduct a product portfolio review in a multi-disciplinary setting utilizing a number of working sessions over a period of four to six months. The process identified product line gaps and strategies to fill the gaps. It prioritized therapeutic areas and research and development projects. The outcome is a consensus strategy understood by the senior management team designed to insure the short-, intermediate- and long-term sustainability of the business within budgetary constraints.
Due Diligence – acted as team members with various client due diligence teams reviewing a myriad of pharmaceutical, medical equipment, medical device and in-vitro diagnostic products and/or company opportunities. While generally MMC is involved in all phases of the due diligence process, participation has also been limited to leading the due diligence team, conducting the manufacturing due diligence, evaluating the global market opportunity, creating the valuation model, valuing the transaction, and assisting in negotiations.
Planning Workshops – worked with the senior management team to define the issues most critical for both short- and long-term success. Translated industry trends into specific company opportunities and threats. Brainstormed alternatives to capitalize on the opportunities and to address the threats. Established next steps, assigned responsibilities, and defined what was expected from whom and by when. Assisted management after the workshop, as required, to translate insights into action.
Strategic Planning – interviewed senior management, worked with staffs to develop required information, conducted planning workshops, modeled the business, developed the strategic plan formats/forms, and drafted the strategic plan, circulated the plan for editions/comments, and finalized the plan for senior management, board of directors, and key investor/lenders use.
Business Model – worked with client management to develop a model of the business to assist in evaluating different financing alternatives.
identify those key factors that management must focus upon to maintain or create a profitable and competitive marketplace position over the next ten years. The emphasis has been to develop action plans to lead and capitalize on industry change to create competitive advantage.
Postmortem Review – conducted a review of a late stage product that failed to get regulatory approval in Europe and the United States. Internal, thought leader, regulatory, clinical, and focus group interviews identified why the product was not approved by the respective regulatory agencies. Communications and target product profile, “TPP”, failures were identified.
Environmental Audits – are designed to identify and translate environmental changes into actionable plans to capitalize on industry change to maintain and/or create a competitive advantage. Reviews incorporate all the stakeholders in the healthcare ecosystem. The focus is to present trends that will influence or drive market change which presents opportunities or threats to the client organization, its going forward investments, and/or its product offering.
Global Market Entry Strategy – assisted the senior management team in the definition and prioritization of the global product development, registration, and launch strategy for a new product.
Product/Market Assessments – for all major developed (e.g., United States, Canada, European Union, Japan) and emerging markets (e.g., China, India, Brazil, Russia, etc.) worldwide.
Commercialization Organizations – assisted the senior management team in developing commercial organizational structures for North America, Europe, tender markets, and developing country markets.
Global Regulatory Pathway Requirements – Prepared a reference book outlining the processes to get product and reimbursement approval for a specific product in the top 35 markets worldwide.
Therapeutic Area/Product Workshop – conducted a brand team workshop to define the implications of changing industry trends on brands and the therapeutic area. The objective was to break “group think” by challenging internal assumptions. Participants were walked through all the major segments that comprise the U.S. healthcare system in order to define how changing norms would affect marketing and strategic plans. The last two hours focused on the competencies and organizational structure requirements for current versus future success. Issues that required further exploration were defined.
Target Product Profile – conducted a review of a product that failed to get regulatory approval in Europe and the United States. Identified why the product was not approved by the respective regulatory agencies. Failures in the target product profile, “TPP”, were identified. MMC defined a new TPP which would expand the market and justify additional development and clinical trial investments to get the product approved.
Licensing Opportunities – screened both marketed products and pipeline products, utilizing MMC’s proprietary WebReporter System, to identify potential in-licensing opportunities to fill projected sales gaps. Projects have included all therapeutic areas.
Identify Targets And Schedule Meetings – conducted a strategic portfolio review, defined gaps, and developed strategies to fill the product portfolio and pipeline. Thereafter, conducted therapeutic/product reviews to identify potential opportunities. This was followed by an MMC Opportunity Ranking Workshop where the client team ranked potential opportunities and the contact strategy for each . Thereafter, MMC identified the right person to contact in each company, contacted the company, and set up meetings between the client and the company. Support included the preparation of briefing packages for client personnel to insure they were prepared for the meeting, confirmatory notes to the prospective companies confirming the appointments, and preparation of the presentation that would be delivered by the client during the respective company meetings.
Disease Area Competitive Landscape Review – defined the disease area and the client’s current target markets. Estimated market size by country and potential entry barriers. Presented a product positioning analysis and conducted a marketed products and pipeline review for the major countries. Prepared proprietary MMC disease specific perceptual maps for the major markets and SWOT analyses for the major competitive products as well as product profiles for all products.
CONTACT - For more information, please contact your MMC representative or Edmund (Ed) L. Valentine, Principal, at: 203-961-9352 or at email@example.com to schedule a convenient time to discuss your project.